VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $220,000 | -71.9% | 13,798 | +214.2% | 0.57% | +117.6% |
| Q3 2015 | $784,000 | +165.8% | 4,392 | +231.2% | 0.26% | +133.9% |
| Q2 2015 | $295,000 | -52.2% | 1,326 | -57.3% | 0.11% | -65.9% |
| Q1 2015 | $617,000 | +124.4% | 3,106 | +47.9% | 0.33% | +412.5% |
| Q3 2014 | $275,000 | -60.3% | 2,100 | -60.0% | 0.06% | -58.7% |
| Q1 2014 | $692,000 | +94.9% | 5,254 | +54.5% | 0.16% | -27.9% |
| Q3 2013 | $355,000 | – | 3,400 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |